RaQualia Pharma Inc. - Product Pipeline Review - 2016

  • ID: 3832306
  • Company Profile
  • 43 pages
  • Global Markets Direct
  • RaQualia Pharma Inc
1 of 4
RaQualia Pharma Inc. - Product Pipeline Review - 2016

Summary

‘RaQualia Pharma Inc. - Product Pipeline Review - 2016’, provides an overview of the RaQualia Pharma Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by RaQualia Pharma Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of RaQualia Pharma Inc.
- The report provides overview of RaQualia Pharma Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses RaQualia Pharma Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features RaQualia Pharma Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate RaQualia Pharma Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for RaQualia Pharma Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding RaQualia Pharma Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

RaQualia Pharma Inc. Snapshot

RaQualia Pharma Inc. Overview

Key Information

Key Facts

RaQualia Pharma Inc. - Research and Development Overview

Key Therapeutic Areas

RaQualia Pharma Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

RaQualia Pharma Inc. - Pipeline Products Glance

RaQualia Pharma Inc. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

RaQualia Pharma Inc. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

RaQualia Pharma Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

RaQualia Pharma Inc. - Drug Profiles

tegoprazan

Product Description

Mechanism of Action

R&D Progress

RQ-00000010

Product Description

Mechanism of Action

R&D Progress

RQ-00310941

Product Description

Mechanism of Action

R&D Progress

RQ-00000774

Product Description

Mechanism of Action

R&D Progress

RQ-00201894

Product Description

Mechanism of Action

R&D Progress

RQ-00202730

Product Description

Mechanism of Action

R&D Progress

RQ-00203066

Product Description

Mechanism of Action

R&D Progress

RQ-00203078

Product Description

Mechanism of Action

R&D Progress

RQ-00433412

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Block Cav3.2 for Neuropathic Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Block Nav1.7 Sodium Channel for Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Block Nav1.8 Sodium Channel for Pain

Product Description

Mechanism of Action

R&D Progress

RQ-00434739

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

RaQualia Pharma Inc. - Pipeline Analysis

RaQualia Pharma Inc. - Pipeline Products by Target

RaQualia Pharma Inc. - Pipeline Products by Route of Administration

RaQualia Pharma Inc. - Pipeline Products by Molecule Type

RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action

RaQualia Pharma Inc. - Recent Pipeline Updates

RaQualia Pharma Inc. - Dormant Projects

RaQualia Pharma Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 43List of Tables

RaQualia Pharma Inc., Key Information

RaQualia Pharma Inc., Key Facts

RaQualia Pharma Inc. - Pipeline by Indication, 2016

RaQualia Pharma Inc. - Pipeline by Stage of Development, 2016

RaQualia Pharma Inc. - Monotherapy Products in Pipeline, 2016

RaQualia Pharma Inc. - Phase III, 2016

RaQualia Pharma Inc. - Phase I, 2016

RaQualia Pharma Inc. - Preclinical, 2016

RaQualia Pharma Inc. - Discovery, 2016

RaQualia Pharma Inc. - Pipeline by Target, 2016

RaQualia Pharma Inc. - Pipeline by Route of Administration, 2016

RaQualia Pharma Inc. - Pipeline by Molecule Type, 2016

RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action, 2016

RaQualia Pharma Inc. - Recent Pipeline Updates, 2016

RaQualia Pharma Inc. - Dormant Developmental Projects,2016

RaQualia Pharma Inc., Other Locations

RaQualia Pharma Inc., Subsidiaries 41List of Figures

RaQualia Pharma Inc. - Pipeline by Top 10 Indication, 2016

RaQualia Pharma Inc. - Pipeline by Stage of Development, 2016

RaQualia Pharma Inc. - Monotherapy Products in Pipeline, 2016

RaQualia Pharma Inc. - Pipeline by Top 10 Target, 2016

RaQualia Pharma Inc. - Pipeline by Route of Administration, 2016

RaQualia Pharma Inc. - Pipeline by Molecule Type, 2016

RaQualia Pharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll